Benign Conditions

Latest News

Key FDA decisions urologists can expect in the first half of 2025
Key FDA decisions urologists can expect in the first half of 2025

January 28th 2025

Check out the key regulatory decisions set to happen early this year.

FDA grants 510(k) clearance to RELIEF stent for vesicoureteral reflux
FDA grants 510(k) clearance to RELIEF stent for vesicoureteral reflux

January 14th 2025

In-depth study of microbiomes may lead to better UTI care for patients with spina bifida
In-depth study of microbiomes may lead to better UTI care for patients with spina bifida

January 6th 2025

FDA logo
2024 Urology Times pipeline report

January 1st 2025

ELIMINATE trial: uUTI regimen demonstrates initial tolerability, efficacy
ELIMINATE trial: uUTI regimen demonstrates initial tolerability, efficacy

November 1st 2024

More News

© 2025 MJH Life Sciences

All rights reserved.